Dr. K

Professor Dr. K : Innovating Global Healthcare through Regenerative Medicine, Cellular Therapy, and Stem Cell Advancements

A distinguished academician and consultant, Dr. Sriwatanakul brings a wealth of expertise in pharmacology, toxicology, and clinical research to his current endeavors. His contributions have significantly impacted drug safety, regulatory policy, and therapeutic advancements in Thailand and beyond.

Education

• Ph.D., Pharmacology, Mahidol University, 1978

• M.D., Medicine (with Honors), Mahidol University, 1974

• B.Sc., Medical Science, Mahidol University, 1972

Current Positions

• Professor Emeritus, Faculty of Science, Mahidol University

• Consultant, Thai Food and Drug Administration & Clinical Stem Cells, Thailand Ministry of Public Health

• Senior Scholar, Appointed Subcommittees, Ministry of Public Health

• Practitioner, Functional Medicine, specializing in cardiometabolic disorders

Prior Academic and Medical Appointments

Dr. Sriwatanakul’s career reflects a trajectory of increasing responsibility and leadership within Mahidol University’s academic and research infrastructure:

• Lecturer, Department of Pharmacology, Faculty of Science, Ramathibodi Hospital (April 1974 – April 1975)

• Assistant Professor, Department of Pharmacology, Faculty of Science, Mahidol University (May 1975 – August 1979)

• Chairman, Department of Pharmacology, Faculty of Science, Mahidol University (August 1979 – July 1985)

• Director, Toxicology Graduate Program, Faculty of Graduate Studies, Mahidol University (April 1984 – March 1988)

• Deputy Dean, Faculty of Graduate Studies, Mahidol University (June 1984 – January 1989 & January 1992 – April 1995)

• Assistant to the President, Foreign Relations and Research, Mahidol University (February 1989 – April 1990)

• Vice President, Research and Foreign Relations, Mahidol University (May 1990 – December 1991)

Other Institutional Affiliations

• Adjunct Scholar, Centre for the Study of Drug Development, Tufts University, Boston, USA

• Member, The Medical Association of Thailand

• Member, The Pharmacological and Therapeutic Society of Thailand

• Member, The Toxicological Society of Thailand

Awards and Fellowships

Dr. Sriwatanakul’s scholarly achievements have been recognized through prestigious awards and fellowships, facilitating international collaborations and advanced research training:

• British Council Research Fellow in Pharmacology, University of Leicester, Leicester, UK (September 1978 – July 1979)

• Merck International Fellow in Clinical Pharmacology, University of Rochester, Rochester, New York, USA (January 1981 – December 1982)

• British Council Visiting Scientist, Department of Clinical Pharmacology, University of Edinburgh, Edinburgh, UK (December 1987 – June 1988)

• UICC: Yamagiwa-Yoshisa Memorial International Cancer Study Grant, Institute of Cancer Research – The Royal Marsden Hospital, Sutton, UK (November 1988 – January 1989)

Current Research Areas

Dr. Sriwatanakul’s current research interests encompass a range of critical areas in pharmacology and therapeutics:

• Clinical Trials of Novel Pharmacokinetics

• Application of Clinical Pharmacokinetics

• Development and Validation of Traditional Thai Herbal Medications

• Pharmacoepidemiology and Drug Safety

• Investigation of Neuromuscular Disorders

A Pioneer in Anti-Aging and Regenerative Medicine and Innovation of Cellular Therapy, Immunotherapies, and Stem Cells.

Professor Dr. Kampon Sriwatanakul is a distinguished figure in the fields of regenerative medicine, pharmacology, and medical innovation. He serves as the President and CEO of multiple organizations. His work is pivotal in advancing stem cell therapies, medical tourism, and innovative treatments within the global health and wellness sector.

Academic and Professional Background

Dr. Sriwatanakul earned his Bachelor of Science, Doctor of Medicine (MD), and Ph.D. in Pharmacology from Mahidol University, Thailand. His early career includes significant contributions as an Associate Professor at Mahidol University and as a consultant to the Thai Food and Drug Administration (FDA). He has also been involved with Thailand’s National Innovation Agency, coordinating medical innovation projects.

Innovations and Leadership

As a visionary in medical science, Dr. Sriwatanakul has been instrumental in developing bioartificial liver technologies, mesenchymal stem cell therapies, and bioidentical hormone treatments. His contributions to medical science include receiving the National Innovation Award for Medical Innovation in 2006. In addition to his leadership in healthcare, he promotes anti-aging and regenerative medicine, focusing on creating advanced medical centers.

Global Impact

Dr. Sriwatanakul is a prominent advocate for Thailand as a leading hub for medical tourism and innovative healthcare. His efforts extend to the global stage, contributing to advancements in stem cell banking, cell therapy, and cosmetic and reconstructive medicine. He actively participates in conferences and collaborates with international organizations to expand the boundaries of healthcare innovation.

Dr. Kampon Sriwatanakul’s enduring contributions to healthcare exemplify his commitment to transforming patient care through science, innovation, and collaboration.

Dr. Kampon Sriwatanakul: A Retrospective on Publications and Scientific Contributions

This compilation highlights Dr. Kampon Sriwatanakul’s extensive research across diverse areas within pharmacology, toxicology, and clinical medicine, spanning nearly two decades. His work demonstrates a commitment to understanding drug interactions, adverse reactions, and therapeutic efficacy, with a particular focus on the Thai population.

1998-1998: Exposure Biomarkers and Diuretic Effects

Makarananda, K., Pengpan, U., Srisakulthong, M., Yoovathaworn, K., & Sriwatanakul, K. (1998). Monitoring of aflatoxin exposure by biomarkers. Journal of Toxicological Sciences, 23(Suppl 11), 155-159. https://www.ncbi.nlm.nih.gov/pubmed/9760454

This study investigated the use of biomarkers for monitoring aflatoxin exposure, a significant public health concern in regions with high dietary exposure to these mycotoxins. Aflatoxins are potent carcinogens produced by certain molds that can contaminate food crops. This research contributed to methodologies for assessing human exposure and risk.

Muangman, V., Thithapanda, A., Yoovathaworn, K., Supavilai, P., Arunnopparat, W., & Sriwatanakul, K. (1998). A study on diuretic effects of Pluchea indica in man. Thai Journal of Urology, 19, 116-128.

This research explored the diuretic properties of Pluchea indica, a plant traditionally used in Thai medicine. The study examined its effects on fluid balance in humans, providing a scientific basis for its traditional use as a diuretic.

1995: Antiflatulents and Functional Dyspepsia

Sriwatanakul, K., & Sriwatanakul, K. (1995). The efficacy and side effects of antiflatulents in the treatment of functional dyspepsia. Naresuan University Journal, 3, 1-4.

This paper evaluated the clinical effectiveness and tolerability of antiflatulent medications in managing functional dyspepsia, a common gastrointestinal disorder characterized by upper abdominal discomfort, bloating, and nausea.

1993: Paracetamol Absorption in Vegetarians

Prescott, L. F., Yoovathaworn, K., Makarananda, K., Saivises, R., & Sriwatanakul, K. (1993). Impaired absorption of paracetamol in vegetarians. British Journal of Clinical Pharmacology, 36(3), 237-240. https://www.ncbi.nlm.nih.gov/pubmed/9114910

This study revealed that vegetarians may experience reduced absorption of paracetamol (acetaminophen), a widely used analgesic and antipyretic. This finding has implications for dosing adjustments in vegetarian patients to ensure adequate pain relief or fever control.

1990-1986: Renal Dopamine, Hypertension, and Drug Metabolism

Lee, M. R., Critchley, J. A., Gordon, C. J., Makarananda, K., Sriwatanakul, K., Balali-Mood, M., & Boye, G. L. (1990). Ethnic differences in the renal sodium-dopamine relationship: A possible explanation for regional variation in the prevalence of hypertension? American Journal of Hypertension, 3(2), 100S-103S.

Highlighted ethnic variations in how the kidneys handle sodium and dopamine, potentially explaining why hypertension rates differ across regions.

Critchley, J. A., Sriwatanakul, K., Charuchinda, C., Balali-Mood, M., Boye, G. L., Chan, T. Y., Brocklesby, N. C., & Lee, M. R. (1990). Ethnic difference in the renal dopamine response to an oral salt load. Journal of Human Hypertension, 4(2), 91-93. [Link Not Available]

Examined how different ethnicities respond to salt intake in terms of dopamine production in the kidneys, linking this to potential hypertension risks.

Critchley, J. A., Lee, M. R., Gordon, C. J., Makarananda, K., Sriwatanakul, K., Balali-Mood, M., & Boye, G. L. (1989). Ethnic differences in the renal sodium-dopamine relationship: A possible explanation for regional variation in the prevalence of hypertension? European Journal of Clinical Pharmacology, 37(6), 559-562. https://link.springer.com/article/10.1007/BF00542046

This study investigated the relationship between renal sodium handling and dopamine production in different ethnic groups, exploring its potential role in regional variations in hypertension prevalence.

Sriwatanakul, K. (1989). Trials of dipyrone in Thailand. The Lancet, 333(8641), 788. [Link Not Available]

This letter to the editor likely discussed clinical trials involving dipyrone (metamizole), an analgesic and antipyretic drug, within the Thai population, potentially addressing efficacy or safety concerns.

Komindr, S., Sriwatanakul, K., & Sriwatanakul, K. (1988). Double-blind comparison study to determine the efficacy and safety of dexfenfluramine in the treatment of obese patients. International Medicine, 4(2), 65-68.

This study assessed the effectiveness and safety of dexfenfluramine, an anorectic agent, in treating obesity through a double-blind, controlled trial.

Critchley, J. A., Makarananda, K., Balali-Mood, M., Sriwatanakul, K., & Lee, M. R. (1988). Further ethnic differences in the renal dopamine relationship: Its uncoupling in the Iranian but not in Thai normotensive subject. Journal of Hypertension, 6(Suppl 4), S623-S625. [Link Not Available]

Explored how dopamine functions in the kidneys of Iranian and Thai individuals with normal blood pressure, finding differences that might relate to blood pressure control.

Sriwatanakul, K. (1988). Mechanism of action of anorexiant agents—Amphetamine and other medications. Medicographia, 10(1), 22-23.

This article likely reviewed the pharmacological mechanisms by which amphetamine and other medications exert their anorexiant (appetite-suppressing) effects, potentially discussing their impact on neurotransmitter systems and metabolic pathways.

Yanapirut, P., & Sriwatanakul, K. (1987). Prospective study of adverse reactions of anticancer medications in Thai patients. Journal of the Medical Association of Thailand, 70(8), 448-454. https://www.ncbi.nlm.nih.gov/pubmed/3681169

This prospective study examined the incidence and nature of adverse drug reactions experienced by Thai patients undergoing cancer treatment, providing valuable data for improving patient safety and management.

Sriwatanakul, K. (1987). Need for chemicals safety information in Thailand. Journal of Toxicological Sciences, 12(3), 285-286. https://www.ncbi.nlm.nih.gov/pubmed/3625826

This short communication emphasized the importance of accessible chemical safety information in Thailand to protect public health and the environment.

Yoovathawon, K. C., Sriwatanakul, K., & Thithapandha, A. (1986). Influence of caffeine on aspirin pharmacokinetics. European Journal of Drug Metabolism and Pharmacokinetics, 11(1), 71-76.

This study investigated how caffeine consumption affects the way aspirin is processed in the body, specifically looking at how it’s absorbed, distributed, metabolized, and eliminated.

Unchern, S., Unchern, S., Chumsawat, P., Sriwatanakul, K., & Limsuwan, A. (1986). Psychomotor performances and subjective feeling studies with antihistamines. Journal of the Medical Association of Thailand, 69(4), 203-209.

This research explored the impact of antihistamines on psychomotor performance (skills involving mental processing and physical movement) and subjective feelings, relevant to understanding their effects on alertness and cognitive function.

Sriwatanakul, K., & Pothisiri, P. (1986). Adverse reaction assessment in Thailand. Medical Toxicology, 1(Suppl 1), 105-109.

This publication likely detailed the methodologies and infrastructure for assessing adverse drug reactions in Thailand, contributing to pharmacovigilance efforts and patient safety.

1985-1979: Early Career and Foundational Research

Makarananda, K., Sriwatanakul, K., Pothsiri, P., Eamrungroj, S., Charoonroj, P., & Pongprayoon, U. (1985). Prospective study of adverse drug reactions of antihypertensive medications in Thai outpatients. Journal of the Medical Association of Thailand, 68(5), 229-236.

A prospective study that examined adverse drug reactions among Thai outpatients taking antihypertensive medications.

Pothisiri, P., Makarananda, K., Sriwatanakul, K., Chroonroj, P., Pongprayoon, U., & Eamungroj, S. (1984). Prospective study of adverse reactions of antiepileptic medications in Thai outpatients. Thai Journal of Pharmacology, 6(1), 1-10.

A prospective study that focused on the adverse reactions to antiepileptic drugs in Thai outpatients.

Sriwatanakul, K., McCormick, K., & Woolf, P. (1984). Thyrotropin (TSH)-induced hyperthyroidism: response of TSH to dopamine and its agonists. The Journal of Clinical Endocrinology & Metabolism, 58(2), 255-259. https://www.ncbi.nlm.nih.gov/pubmed/6420433

This study investigated the effects of dopamine and dopamine agonists on thyrotropin (TSH) secretion in patients with TSH-induced hyperthyroidism, providing insights into the neuroendocrine regulation of thyroid function.

Sriwatanakul, K., Lasagna, L., & Cox, C. (1983). Evaluation of current clinical trial methodology in analgesimetry based on experts’ opinions and analysis of several analgesic studies. Clinical Pharmacology & Therapeutics, 34(3), 277-283. https://www.ncbi.nlm.nih.gov/pubmed/6883903

An evaluation of clinical trial methods in pain measurement, based on expert opinions and data from analgesic studies.

Sriwatanakul, K., Kelvin, W., Lasagna, L., Calimlim, J. F., Weis, O. F., & Mehta, G. (1983). Studies with different types of visual analog scales for measurement of pain. Clinical Pharmacology & Therapeutics, 34(2), 234-239. https://www.ncbi.nlm.nih.gov/pubmed/6308506

A study that looked at different visual analog scales and how they measure pain.

Weintraub, M., Sriwatanakul, K., Sundaresan, P. R., Weis, O. F., & Dorn, M. (1983). Extended-release fenfluramine: Patient acceptance and efficacy of evening dosing. Clinical Pharmacology & Therapeutics, 33(5), 621-627. https://www.ncbi.nlm.nih.gov/pubmed/6340909

Examined patient acceptance and the effectiveness of taking an extended-release form of fenfluramine (an appetite suppressant) in the evening.

Weis, O. F., Sriwatanakul, K., Alloza, J. L., Weintraub, M., & Lasagna, L. (1983). Attitudes of patients, housestaff, and nurses towards post-operative analgesic care. Anesthesia & Analgesia, 62(1), 70-74. [https://journals.lww.com/anesthesia-analgesia/Citation/1983/01000/Attitudes_of_Patients,_Housestaff,_and_Nurses.14.aspx]

This study assessed the attitudes of patients, medical residents, and nurses regarding postoperative pain management, highlighting potential gaps in communication and care.

Weis, O. F., Sriwatanakul, K., Weintraub, M., & Lasagna, L. (1983). Reduction of anxiety and postoperative analgesic requirements by audiovisual instruction. The Lancet, 321(8314), 43-44. [Link Not Available]

Evaluated whether showing patients audiovisual information could decrease their anxiety and need for pain medication after surgery.

Wang, Z. X., & Sriwatanakul, K. (1983). Medications used for the treatment of dementia. Rational Drug Therapy, 17(5), 1-4. [Link Not Available]

This article likely provided an overview of medications used to manage dementia symptoms, potentially discussing their mechanisms of action, efficacy, and side effects.

Sriwatanakul, K., & Mehta, G. (1983). Update review of clinically significant drug interactions. Drug Therapy, 13, 41-44.

An updated review of important drug interactions in clinical practice.

Sriwatanakul, K., & Weintraub, M. (1983). Understanding food-drug interactions. Comprehensive Therapy, 9(1), 6-11.

This article focused on understanding how food can interact with drugs.

Makarananda, K., & Sriwatanakul, K. (1983). Cancer chemotherapy: Drug interaction. Thai Cancer Journal, 9(2), 55-59.

This article discussed drug interactions related to cancer chemotherapy.

Sriwatanakul, K., Lasagna, L., Calimlim, J. F., Wardell, W. M., Cox, C., Weis, O. F., & Mehta, G. (1982). Analgesic efficacy of parenteral metkephamid acetate in the treatment of postoperative pain. The Lancet, 319(8339), 1374-1376.

An assessment of how well metkephamid acetate, given by injection, worked to relieve pain after surgery.

Calimlim, J. F., Wardell, W. M., Sriwatanakul, K., Lasagna, L., & Cox, C. (1982). Analgesic efficacy of parenteral metkephamid acetate in the treatment of postoperative pain. The Lancet, 1(8287), 1374-1375.

This study evaluated the analgesic efficacy of parenteral metkephamid acetate in managing postoperative pain.

Sriwatanakul, K., Kelvin, W., & Lasagna, L. (1982). The quantification of pain: An analysis of words used to describe pain and analgesia in clinical trials. Clinical Pharmacology & Therapeutics, 32(2), 143-148. https://www.ncbi.nlm.nih.gov/pubmed/7094502

This paper analyzed the language used to describe pain and analgesia in clinical trials, contributing to a better understanding of pain assessment methodologies.

Sriwatanakul, K., & Weintraub, M. (1982). Food-drug interaction: An overlooked clinical problem. Drug Therapy, 12(1), 157-159.

This article discussed food and drug interactions as a clinical problem.

Sriwatanakul, K. (1982). Minimizing the risk of antipsychotic-associated seizures. Drug Therapy, 12, 207-250. [OrcID: Verify if Kampon Sriwatanakul has an OrcID and include it here if available]

This publication likely provided guidance on strategies to reduce the risk of seizures associated with antipsychotic medications, a significant concern in psychiatric practice.

Sriwatanakul, K., & Weis, O. (1982). Using antipsychotic medications during pregnancy. Drug Therapy, 12, 247-250.

Addressed the use of antipsychotics during pregnancy.

Weis, O., & Sriwatanakul, K. (1982). Methotrimeprazine analgesia. Drug Therapy, 12(1), 143-147.

Discussed the use of methotrimeprazine as an analgesic.

Weis, O., Sriwatanakul, K., & Weintraub, M. (1982). Methotrimeprazine in acute porphyria. South African Medical Journal, 61(52), 985-986.

A discussion on the use of methotrimeprazine in acute porphyria.

Weis, O., Sriwatanakul, K., & Weintraub, M. (1982). Treatment of post-herpetic neuralgia and acute herpetic pain with amitriptyline and perphenazine. South African Medical Journal, 62(9), 274-275. https://www.ncbi.nlm.nih.gov/pubmed/7112329

This study investigated the effectiveness of amitriptyline and perphenazine in treating post-herpetic neuralgia and acute herpetic pain.

Sriwatanakul, K. (1982). A critical examination of drug interactions. Thai Journal of Pharmacology, 4(1), 17-35.

An examination of drug interactions.

Sriwatanakul, K. (1982). A critical examination of drug interactions. Thai Journal of Pharmacology, 4(3), 143-151.

An examination of drug interactions.

Sriwatanakul, K., & Weintraub, M. (1981). Analgesic use in the treatment of cancer pain. Thai Cancer Journal, 7(2), 111-116.

This article likely discussed the use of analgesics in managing cancer pain, potentially addressing different pain management strategies and considerations specific to cancer patients.

Sriwatanakul, K. (1981). Lowering of seizure threshold induced by phenothiazine therapy. Thai Journal of Pharmacology, 3(2), 95-100.

This article likely examined how phenothiazine medications, a class of antipsychotics, can lower the seizure threshold, increasing the risk of seizures in susceptible individuals.

Sriwatanakul, K., & Nahorski, S. R. (1980). Disposition and activity of beta-adrenoceptor antagonists in the rat using an ex vivo receptor binding assay. European Journal of Pharmacology, 66(2-3), 169-178. https://www.ncbi.nlm.nih.gov/pubmed/6108223

This study investigated the disposition and activity of beta-adrenoceptor antagonists (beta-blockers) using an ex vivo receptor binding assay, providing insights into their pharmacological mechanisms.

Nahorski, S. R., & Sriwatanakul, K. (1979). Analysis of the activity and distribution of beta-adrenoceptor antagonists using an ex vivo receptor binding assay. (Proceedings) British Journal of Pharmacology, 67(3), 415P.

This conference proceeding likely presented early findings on the activity and distribution of beta-adrenoceptor antagonists, utilizing an ex vivo receptor binding assay.

Additional Research 

Jeenapongsa, R., Yoovathaworn, K., Sriwatanakul, K. M., Pongprayoon, U., & Sriwatanakul, K. (2003). Anti-inflammatory activity of (E)-1-(3,4-dimethoxyphenyl) butadiene from Zingiber cassumunar Roxb. Journal of Ethnopharmacology, 87(2-3), 143-148. https://www.ncbi.nlm.nih.gov/pubmed/12860299

This study identified and investigated the anti-inflammatory properties of a compound extracted from Zingiber cassumunar Roxb (a type of ginger), with potential applications in traditional medicine.